ASIC vs. AUPH
ASIC (Ategrity Specialty Holdings LLC) and AUPH (Aurinia Pharmaceuticals Inc.) are both stocks. ASIC operates in Insurance - Property & Casualty (Financial Services), while AUPH operates in Biotechnology (Healthcare). Over the past year, ASIC returned 20.70% vs 41.85% for AUPH. Their 0.04 correlation means their historical movements had little consistent relationship.
Performance
ASIC vs. AUPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ASIC achieves a 14.33% return, which is significantly higher than AUPH's -6.71% return.
ASIC
- 1D
- 0.71%
- 1M
- -5.51%
- 6M
- 34.87%
- YTD
- 14.33%
- 1Y
- 20.70%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 1.38%
AUPH
- 1D
- -0.80%
- 1M
- -4.68%
- 6M
- 2.41%
- YTD
- -6.71%
- 1Y
- 41.85%
- 3Y*
- 12.50%
- 5Y*
- 1.88%
- 10Y*
- 15.71%
- ALL TIME*
- 11.66%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $1.69M | $1.77M | $1.59M | |
| $16.20M | $20.37M | $24.11M |
ASIC vs. AUPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
ASIC Ategrity Specialty Holdings LLC | 14.33% | -11.16% |
AUPH Aurinia Pharmaceuticals Inc. | -6.71% | 95.71% |
Correlation
The correlation between ASIC and AUPH is 0.07, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.07 |
Correlation (All Time) Calculated using the full available price history since Jun 11, 2025 | 0.04 |
Fundamentals
ASIC:
$1.15B
AUPH:
$1.91B
ASIC:
$2.20
AUPH:
$2.17
ASIC:
10.93
AUPH:
6.86
ASIC:
0.05
AUPH:
0.00
ASIC:
2.26
AUPH:
6.86
ASIC:
1.80
AUPH:
3.61
ASIC:
$516.89M
AUPH:
$298.30M
ASIC:
$155.25M
AUPH:
$267.70M
ASIC:
$63.36M
AUPH:
$153.45M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ASIC vs. AUPH — Risk / Return Rank
ASIC
AUPH
ASIC vs. AUPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Ategrity Specialty Holdings LLC (ASIC) and Aurinia Pharmaceuticals Inc. (AUPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ASIC | AUPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.99 | ||
| Sortino ratioReturn per unit of downside risk | -1.02 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.28 | -0.16 |
| Calmar ratioReturn relative to maximum drawdown | 0.68 | 3.05 | -2.37 |
| Martin ratioReturn relative to average drawdown | 1.27 | 7.13 | -5.86 |
Loading charts...
Drawdowns
ASIC vs. AUPH - Drawdown Comparison
The maximum ASIC drawdown since its inception was -33.63%, smaller than the maximum AUPH drawdown of -87.58%. Use the drawdown chart below to compare losses from any high point for ASIC and AUPH.
Loading charts...
Drawdown Indicators
| ASIC | AUPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -33.63% | -87.58% | +53.95% |
Max Drawdown (1Y)Largest decline over 1 year | -29.91% | -20.09% | -9.82% |
Max Drawdown (3Y)Largest decline over 3 years | — | -52.80% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -87.58% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -87.58% | — |
Current DrawdownCurrent decline from peak | -6.14% | -55.02% | +48.88% |
Average DrawdownAverage peak-to-trough decline | -17.61% | -49.23% | +31.62% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.93% | 8.57% | +7.36% |
Volatility
ASIC vs. AUPH - Volatility Comparison
Ategrity Specialty Holdings LLC (ASIC) has a higher volatility of 15.76% compared to Aurinia Pharmaceuticals Inc. (AUPH) at 10.01%. This indicates that ASIC's price experiences larger fluctuations and is considered to be riskier than AUPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ASIC | AUPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.76% | 10.01% | +5.75% |
Volatility (6M)Calculated over the trailing 6-month period | 37.04% | 27.29% | +9.75% |
Volatility (1Y)Calculated over the trailing 1-year period | 48.77% | 43.47% | +5.30% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 48.59% | 66.66% | -18.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 48.59% | 73.52% | -24.93% |
Dividends
ASIC vs. AUPH - Dividend Comparison
Neither ASIC nor AUPH has paid dividends to shareholders.
Financials
ASIC vs. AUPH - Financials Comparison
This section allows you to compare key financial metrics between Ategrity Specialty Holdings LLC and Aurinia Pharmaceuticals Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ASIC vs. AUPH - Profitability Comparison
ASIC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Ategrity Specialty Holdings LLC reported a gross profit of -67.08M and revenue of 148.48M. Therefore, the gross margin over that period was -45.2%.
AUPH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Aurinia Pharmaceuticals Inc. reported a gross profit of 71.20M and revenue of 77.71M. Therefore, the gross margin over that period was 91.6%.
ASIC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Ategrity Specialty Holdings LLC reported an operating income of -34.23M and revenue of 148.48M, resulting in an operating margin of -23.1%.
AUPH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Aurinia Pharmaceuticals Inc. reported an operating income of 41.42M and revenue of 77.71M, resulting in an operating margin of 53.3%.
ASIC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Ategrity Specialty Holdings LLC reported a net income of 33.45M and revenue of 148.48M, resulting in a net margin of 22.5%.
AUPH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Aurinia Pharmaceuticals Inc. reported a net income of 34.36M and revenue of 77.71M, resulting in a net margin of 44.2%.
Frequently Asked Questions
ASIC and AUPH have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ASIC has higher volatility (15.76%) compared to AUPH (10.01%). In terms of maximum drawdown, ASIC dropped -33.63% vs AUPH's -87.58%.
AUPH currently has the higher Sharpe Ratio (1.41 vs 0.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ASIC and AUPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer